Tradestie Institutional Equity Comparison Engine

ABCL vs HERZ โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

HERZ Overall Edge

HERZ Captures Institutional Edge (3โ€“1 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Herzfeld Credit Income Fund, Inc. Common Stock (HERZ) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while ABCL counters with relative strength in Valuation. Fundamentally, ABCL trades at 27.6x Forward P/E with -298.0% operating margin (+18.8% YoY revenue) versus HERZ at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, ABCL sits in BREAKDOWN (32nd %ile IV; Dealer Gamma Walls on Pro) against HERZ sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner ABCL
ABCL 27.6x vs HERZ N/M Fwd P/E
Growth & Margin Winner HERZ
Op Margin -298.0% vs 0.0% ยท YoY +18.8% vs +0.0%
Momentum & Technical Winner HERZ
1Y +168.4% vs +404.3% ยท 52W Pos 57% vs 64%
Options & Structure Winner HERZ
BREAKDOWN (32nd %ile IV) vs UNCLASSIFIED (N/A IV)
ABCL NASDAQ
AbCellera Biologics Inc. Common Shares
Pharmaceutical Preparations
$9.69
-7.45% 1D
Market Cap $3.4B
1M Return -14.78%
1Y Return +168.42%
Forward P/E 27.6x
Unified AI Score
57.1 / 100 HOLD
Tech 33.0 Fund 54.0 Flow 70.0 Mom 64.0
HERZ NASDAQ
Herzfeld Credit Income Fund, Inc. Common Stock
Institutional Equity
$12.96
-0.31% 1D
Market Cap $40.2M
1M Return -13.18%
1Y Return +404.28%
Forward P/E N/M
Unified AI Score
48.7 / 100 HOLD
Tech 60.0 Fund 57.0 Flow 50.0 Mom 59.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ABCL +168.42% HERZ +404.28% Spread: +245.87 pp (HERZ Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ABCL TTM Op. Margin: -298.0% HERZ TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABCL vs HERZ. Trailing 12-month operating profitability (ABCL -298.0% vs HERZ 0.0%) and valuation multiples (ABCL 27.6x vs HERZ N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ABCL (5) vs HERZ (5)
Institutional Metric ABCL HERZ Criterion Row Winner
Market Capitalization Scale $3.4B $40.2M Larger Scale ABCL
Trailing P/E Ratio Valuation 27.6x N/M Lower Multiple ABCL
Forward P/E Ratio Valuation 27.6x N/M Lower Multiple ABCL
Revenue Growth (YoY) Growth +18.8% +0.0% Higher Growth ABCL
Operating Margin (TTM) Profitability -298.0% 0.0% Higher Margin HERZ
Net Profit Margin Profitability -218.6% 0.0% Higher Margin HERZ
Return on Equity (ROE) Capital Efficiency -14.6% 0.0% Higher ROE HERZ
52-Week Range Position Momentum 57% ($3โ€“$15) 64% ($2โ€“$19) Stronger Trend HERZ
Beta / 30D Volatility Risk Regime 2.32ฮฒ ยท 85% Vol 0.26ฮฒ ยท 20% Vol Lower Realized Risk HERZ
Unified Institutional Score Composite Signal 57.1 / 100 (HOLD) 48.7 / 100 (HOLD) Higher Composite ABCL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ABCL vs HERZ Buy Guide
ABCL BREAKDOWN
38d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 32nd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ABCL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
HERZ UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live HERZ Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ABCL nor HERZ registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.